Developer docs
API playgroundTry for free, no card

Search company profiles

SentiAR

Full company profile

uuid000074y

Namestring
SentiAR
Legal namestring
SentiAR, Inc.
Websiteurl
sentiar.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

SentiAR is a St. Louis-based digital health and medical device company founded in 2017 that develops augmented reality (AR) visualization technology for intraprocedural clinical use in cardiac electrophysiology. Its flagship product, CommandEP, is the first FDA-cleared holographic cardiac ablation guidance system, providing electrophysiologists with real-time, interactive 3D holographic visualization of patient heart anatomy and electroanatomic mapping data during catheter ablation procedures. The platform runs on Microsoft HoloLens hardware and features a proprietary gaze-dwell control interface that allows physicians to manipulate the display hands-free while maintaining sterility; reported clinical metrics include up to 50% improvement in localization accuracy and a reduction in verbal commands from 1.7 to 0.17 per target point.

The company was co-founded by Dr. Jennifer Avari Silva (CMO, a leading pediatric electrophysiologist at Washington University), Dr. Jonathan Silva (CTO, biomedical engineering faculty), and Michael Southworth (VP of Technology, ex-Boeing and JHUAPL). Its R&D leadership includes Dr. Sharif Razzaque (Director of R&D), a 25-year AR/VR medical veteran who previously held senior roles at Microsoft Mixed Reality and Medtronic and is an inventor on over 20 Medical XR patent applications. SentiAR generates revenue through enterprise hardware sales of the CommandEP system combined with recurring software licensing to hospitals and cardiac catheterization labs, distributed via direct enterprise field sales. Named commercial customers to date include The Valley Hospital in New Jersey, which became the first in the state to use the platform in July 2024, marking the company's transition into early commercial-stage operations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSt Louis, United States
HQ citystring
St Louis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cardiac ablation guidance, augmented reality surgery, electrophysiology visualization, holographic medical imaging, interventional cardiology software
Industry3 codes
PRIMARYHLAHAFAD
Electrophysiology Mapping & Ablation Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAKABAC
Electrophysiology (Heart Rhythm)
SECONDARYHLAHAFAI
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Cardiac Electrophysiology Visualization Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1CommandEP System
TypeHardware Sales
Description

Sale and licensing of the CommandEP augmented reality system to hospitals and cardiac catheterization labs for use during electrophysiology procedures. The system combines proprietary software with Microsoft HoloLens hardware.

sentiar.com
2Software Licensing
TypeSubscription Recurring
Description

Ongoing software licensing and updates for the AR visualization platform used during cardiac ablation procedures

sentiar.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components1 value
Technology or R&D
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1CommandEP
Description

Flagship augmented reality system for cardiac ablation procedures that creates interactive 3D visuals using real-time data from catheters and 3D electroanatomic mapping systems

sentiar.com
+1 more record
Core offering1 text field

SentiAR develops and sells CommandEP, an FDA 510(k)-cleared augmented reality visualization system for cardiac electrophysiology procedures. The platform ingests real-time data from catheters and 3D electroanatomic mapping systems to render interactive 3D holographic displays of patient heart anatomy, which electrophysiologists control hands-free via gaze commands on Microsoft HoloLens hardware during ablation procedures.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Localization accuracy improved by up to 50% within the heart
+2 more records
Product overview1 text field

SentiAR offers a single unified product called CommandEP, an augmented reality visualization platform designed for cardiac electrophysiology procedures. The system integrates real-time data from catheters and 3D electroanatomic mapping systems to generate holographic 3D visuals of the patient's heart anatomy, allowing physicians hands-free control via gaze commands during ablation procedures. The platform runs on Microsoft HoloLens hardware and was cleared by the FDA in September 2020 as the first holographic cardiac ablation guidance system.

Product and service1 record
1CommandEP
CategoryCardiac Electrophysiology Visualization Software
Description

Augmented reality visualization system that creates interactive 3D holographic displays of patient heart anatomy and electroanatomic mapping data in real-time during cardiac ablation procedures, providing hands-free gaze-controlled visualization to improve procedural accuracy. Designed for electrophysiologists and interventional cardiologists performing cardiac ablation procedures (e.g., atrial fibrillation treatment) at hospitals and cardiac catheterization labs.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

The Valley Hospital in New Jersey became the first hospital to perform a cardiac ablation procedure using SentiAR's holographic guidance platform in July 2024, marking the first commercial clinical use of the technology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

SentiAR co-founders Dr. Jennifer Avari Silva and Dr. Jonathan Silva are affiliated with Washington University. The company maintains research collaboration through academic partnerships for clinical trials and product development. Dr. Jonathan Silva is an Assistant Professor of Biomedical Engineering at Washington University.

Strategic tierCoreTypeTechnology or Integration
Description

SentiAR uses Microsoft HoloLens as the delivery platform for its CommandEP augmented reality software. The company leverages Microsoft's mixed reality hardware technology for medical visualization applications.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Sells cardiology imaging systems, cath-lab integration, and intra-procedural visualization tools used during cardiac ablation. Comparable broad incumbent with the resources to add AR visualization layers to its cardiology workflow stack.

TypeEmerging player
Description

Light-field and AR visualization for spine surgery using headset hardware. Comparable emerging clinical AR visualization company with a similar hospital-procurement GTM and focus on intra-procedural 3D anatomical display.

TypeEmerging player
Description

Provides HapticVR surgical training and education simulations using VR headsets. Comparable as an emerging clinical XR company with overlapping physician users in EP and cardiac surgery, though focused on training rather than live intra-procedural visualization.

TypeBroad incumbent
Description

Major vendor of cath-lab and EP interventional imaging equipment (Azurion, EchoNavigator). Comparable as a broad incumbent whose cath-lab visualization and image-guidance portfolio could overlap with SentiAR's hands-free intra-procedural visualization.

TypeDirect peer
Description

Provides 360° VR/AR surgical visualization for neurosurgery and other complex procedures using headsets. Closest direct peer to SentiAR in clinical extended-reality visualization, with comparable enterprise-medtech GTM and hospital-catheterization-lab orientation.

TypeBroad incumbent
Description

Makes the Rhythmia HDx mapping system and a broad portfolio of cardiac ablation catheters. CEO Berk Tas previously worked at Boston Scientific, and the company is one of the three dominant EP mapping-and-ablation vendors whose installed base SentiAR's CommandEP is designed to overlay.

7Abbott
TypeBroad incumbent
Description

Owns the EnSite X EP navigation and mapping system used in cardiac ablation procedures alongside CARTO and Rhythmia. As an EP-mapping incumbent with broad cardiology device franchises, Abbott is a directly comparable large peer whose mapping system feeds the same procedure workflows SentiAR visualizes.

TypeEmerging player
Description

AI-guided cardiac MRI acquisition software for diagnostic cardiology. Comparable emerging cardiac-imaging software company serving the same electrophysiology and cardiology departments that purchase CommandEP, though focused on diagnostic imaging rather than intra-procedural visualization.

TypeEmerging player
Description

Develops VR/AR simulation, planning, and visualization tools for surgery and interventional procedures. Comparable emerging clinical XR company with similar hospital and physician channels and an adjacent product positioning around surgical visualization.

TypeBroad incumbent
Description

Global medtech incumbent and owner of the CARTO 3D electroanatomic mapping system that CommandEP integrates with during cardiac ablation. Medtronic also has interventional imaging and mixed-reality investments, making it the most strategically significant incumbent — both as a data partner and a potential competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors14 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SentiAR

Cardiac Electrophysiology Visualization Softwaresentiar.com

What SentiAR does

SentiAR is a St. Louis-based digital health and medical device company founded in 2017 that develops augmented reality (AR) visualization technology for intraprocedural clinical use in cardiac electrophysiology. Its flagship product, CommandEP, is the first FDA-cleared holographic cardiac ablation guidance system, providing electrophysiologists with real-time, interactive 3D holographic visualization of patient heart anatomy and electroanatomic mapping data during catheter ablation procedures. The platform runs on Microsoft HoloLens hardware and features a proprietary gaze-dwell control interface that allows physicians to manipulate the display hands-free while maintaining sterility; reported clinical metrics include up to 50% improvement in localization accuracy and a reduction in verbal commands from 1.7 to 0.17 per target point.

The company was co-founded by Dr. Jennifer Avari Silva (CMO, a leading pediatric electrophysiologist at Washington University), Dr. Jonathan Silva (CTO, biomedical engineering faculty), and Michael Southworth (VP of Technology, ex-Boeing and JHUAPL). Its R&D leadership includes Dr. Sharif Razzaque (Director of R&D), a 25-year AR/VR medical veteran who previously held senior roles at Microsoft Mixed Reality and Medtronic and is an inventor on over 20 Medical XR patent applications. SentiAR generates revenue through enterprise hardware sales of the CommandEP system combined with recurring software licensing to hospitals and cardiac catheterization labs, distributed via direct enterprise field sales. Named commercial customers to date include The Valley Hospital in New Jersey, which became the first in the state to use the platform in July 2024, marking the company's transition into early commercial-stage operations.

SentiAR firmographics

Firmographics
Name
SentiAR
Legal name
SentiAR, Inc.
Website
https://sentiar.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

SentiAR industry classification

Industry
Product category
Cardiac Electrophysiology Visualization Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAFAD
Electrophysiology Mapping & Ablation Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAKABAC
Electrophysiology (Heart Rhythm)
SECONDARYHLAHAFAI
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

  • Cardiac ablation guidance
  • Augmented reality surgery
  • Electrophysiology visualization
  • Holographic medical imaging
  • Interventional cardiology software

Where SentiAR is headquartered

Location

Headquarters

HQ city
St Louis
HQ country
United States
HQ region
North America

Offices1 record

Markets served

SentiAR business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D

Revenue model

  1. CommandEP System: Sale and licensing of the CommandEP augmented reality system to hospitals and cardiac catheterization labs for use during electrophysiology procedures. The system combines proprietary software with Microsoft HoloLens hardware.
  2. Software Licensing: Ongoing software licensing and updates for the AR visualization platform used during cardiac ablation procedures

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

SentiAR product offering

Product offering

Core offering

SentiAR develops and sells CommandEP, an FDA 510(k)-cleared augmented reality visualization system for cardiac electrophysiology procedures. The platform ingests real-time data from catheters and 3D electroanatomic mapping systems to render interactive 3D holographic displays of patient heart anatomy, which electrophysiologists control hands-free via gaze commands on Microsoft HoloLens hardware during ablation procedures.

Product overview

SentiAR offers a single unified product called CommandEP, an augmented reality visualization platform designed for cardiac electrophysiology procedures. The system integrates real-time data from catheters and 3D electroanatomic mapping systems to generate holographic 3D visuals of the patient's heart anatomy, allowing physicians hands-free control via gaze commands during ablation procedures. The platform runs on Microsoft HoloLens hardware and was cleared by the FDA in September 2020 as the first holographic cardiac ablation guidance system.

Differentiator

Problem solved

Functional benefit

Brands

  • CommandEP: Flagship augmented reality system for cardiac ablation procedures that creates interactive 3D visuals using real-time data from catheters and 3D electroanatomic mapping systems
  • ELVIS (Enhanced Electrophysiology Visualization and Interactive System)

Products and services

  • CommandEP Augmented reality visualization system that creates interactive 3D holographic displays of patient heart anatomy and electroanatomic mapping data in real-time during cardiac ablation procedures, providing hands-free gaze-controlled visualization to improve procedural accuracy. Designed for electrophysiologists and interventional cardiologists performing cardiac ablation procedures (e.g., atrial fibrillation treatment) at hospitals and cardiac catheterization labs.

Quantifiable outcome

  • Localization accuracy improved by up to 50% within the heart
  • +2 more outcomes

Companies that use SentiAR

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

SentiAR technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

SentiAR partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship and core.

  • The Valley HospitalflagshipStrategic or Co-development PartnerThe Valley Hospital in New Jersey became the first hospital to perform a cardiac ablation procedure using SentiAR's holographic guidance platform in July 2024, marking the first commercial clinical use of the technology.
  • Washington University in St. LouiscoreStrategic or Co-development PartnerSentiAR co-founders Dr. Jennifer Avari Silva and Dr. Jonathan Silva are affiliated with Washington University. The company maintains research collaboration through academic partnerships for clinical trials and product development. Dr. Jonathan Silva is an Assistant Professor of Biomedical Engineering at Washington University.
  • MicrosoftcoreTechnology or IntegrationSentiAR uses Microsoft HoloLens as the delivery platform for its CommandEP augmented reality software. The company leverages Microsoft's mixed reality hardware technology for medical visualization applications.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

SentiAR competitors and assessment

Company assessment

Broad incumbents

  • GE HealthCare: Sells cardiology imaging systems, cath-lab integration, and intra-procedural visualization tools used during cardiac ablation. Comparable broad incumbent with the resources to add AR visualization layers to its cardiology workflow stack.
  • Philips Healthcare: Major vendor of cath-lab and EP interventional imaging equipment (Azurion, EchoNavigator). Comparable as a broad incumbent whose cath-lab visualization and image-guidance portfolio could overlap with SentiAR's hands-free intra-procedural visualization.
  • Boston Scientific: Makes the Rhythmia HDx mapping system and a broad portfolio of cardiac ablation catheters. CEO Berk Tas previously worked at Boston Scientific, and the company is one of the three dominant EP mapping-and-ablation vendors whose installed base SentiAR's CommandEP is designed to overlay.
  • Abbott: Owns the EnSite X EP navigation and mapping system used in cardiac ablation procedures alongside CARTO and Rhythmia. As an EP-mapping incumbent with broad cardiology device franchises, Abbott is a directly comparable large peer whose mapping system feeds the same procedure workflows SentiAR visualizes.
  • Medtronic: Global medtech incumbent and owner of the CARTO 3D electroanatomic mapping system that CommandEP integrates with during cardiac ablation. Medtronic also has interventional imaging and mixed-reality investments, making it the most strategically significant incumbent — both as a data partner and a potential competitor.

Emerging players

  • Proprio Vision: Light-field and AR visualization for spine surgery using headset hardware. Comparable emerging clinical AR visualization company with a similar hospital-procurement GTM and focus on intra-procedural 3D anatomical display.
  • FundamentalVR: Provides HapticVR surgical training and education simulations using VR headsets. Comparable as an emerging clinical XR company with overlapping physician users in EP and cardiac surgery, though focused on training rather than live intra-procedural visualization.
  • HeartVista: AI-guided cardiac MRI acquisition software for diagnostic cardiology. Comparable emerging cardiac-imaging software company serving the same electrophysiology and cardiology departments that purchase CommandEP, though focused on diagnostic imaging rather than intra-procedural visualization.
  • ImmersiveTouch: Develops VR/AR simulation, planning, and visualization tools for surgery and interventional procedures. Comparable emerging clinical XR company with similar hospital and physician channels and an adjacent product positioning around surgical visualization.

Direct peers

  • Surgical Theater: Provides 360° VR/AR surgical visualization for neurosurgery and other complex procedures using headsets. Closest direct peer to SentiAR in clinical extended-reality visualization, with comparable enterprise-medtech GTM and hospital-catheterization-lab orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

SentiAR social profiles

Digital presence

SentiAR financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SentiAR leadership team

Management profile

Number of profiles

Profiles6 records

SentiAR funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SentiAR M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SentiAR

What does SentiAR do?

SentiAR develops and sells CommandEP, an FDA 510(k)-cleared augmented reality visualization system for cardiac electrophysiology procedures. The platform ingests real-time data from catheters and 3D electroanatomic mapping systems to render interactive 3D holographic displays of patient heart anatomy, which electrophysiologists control hands-free via gaze commands on Microsoft HoloLens hardware during ablation procedures.

Is SentiAR a public or private company?

SentiAR is a private company. It is classified as venture growth investor backed and is currently operating.

When was SentiAR founded?

SentiAR was founded in 2017. It employs 11 to 50 people.

Where is SentiAR based?

SentiAR is headquartered in St Louis, United States, in the North America region.

How does SentiAR make money?

Two revenue lines are on record. CommandEP System is the primary driver. The others are software Licensing.

Who are SentiAR's main competitors?

Broad incumbents on record are GE HealthCare, Philips Healthcare, Boston Scientific, Abbott and Medtronic. Emerging players are Proprio Vision, FundamentalVR, HeartVista and ImmersiveTouch. Surgical Theater is listed as a direct peer.

Does SentiAR have an API?

No public API is recorded for SentiAR.

What industry is SentiAR in?

SentiAR's product category is Cardiac Electrophysiology Visualization Software. Its primary akta.pro industry code is HLAHAFAD, Electrophysiology Mapping & Ablation Systems, with a secondary code of HLAKABAC, Electrophysiology (Heart Rhythm). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Cardiovascular BusinessVirtual screens could make augmented reality more useful during cardiac ablationA new analysis published in the Journal of Interventional Cardiac Electrophysiology examines the potential of adding customizable virtual screens to St. Louis-based Sentiar's CommandEP mixed reality system for cardiac ablation procedures. The study, which tested the feature on animal models, found that this enhancement allows clinicians to customize their augmented reality environment by integrating data from multiple sources such as electrograms and fluoroscopy into a single spatial layout.American City Business JournalsSentiAR's hands-free headset enables surgeons and physicians to see 3D, mixed-reality, real-time images of patients’ heartsSentiAR's CommandEP is a mixed-reality software that displays a 3D hologram of a patient's heart via a hands-free headset for cardiologists during cardiac ablations. The tool is being piloted at hospitals in Boston, New York, and New Jersey, with plans to expand deployments over the next 24 months.Auganix.orgSentiAR announces second FDA clearance for CommandEP AR interfaceSentiAR has received its second FDA 510K clearance for the CommandEP augmented reality interface, enabling a new integration for cardiac ablation procedures. The system utilizes Magic Leap 2 headsets to provide physicians with real-time, hands-free 3D visualization of patient anatomy. SentiAR anticipates completing new clinical studies for the application later this year.PR NewswireSentiAR Announces Close of $8.5 million Series B FinancingSentiAR, Inc. has closed an $8.5 million Series B financing round led by cultivate (MD) Ventures with participation from MedVenture Partners and several other investors. The company intends to use the capital to launch additional partnerships and expand clinical deployments of its CommandEP augmented reality system for cardiac ablation procedures.VC News DailySentiAR Announces $8.5M Series B RoundSentiAR, a St. Louis-based medical technology company specializing in augmented reality visualization for interventional procedures, closed an $8.5 million Series B financing round. The round was led by cultivate (MD) Ventures and MedVenture Partners, with participation from existing investors TechWald Holding, VCapital, QRM Capital, and Harmonix Fund. The funding will enable SentiAR to expand partnerships and deploy its AR platform for clinical use in cardiac ablation procedures, including atrial fibrillation treatment.PR NewswireSentiAR Closes An Oversubscribed $5.1 Million Series A Round With TechWald Holding As A Strategic ShareholderSentiAR, a St. Louis-based medical technology company specializing in mixed reality visualization for interventional cardiac procedures, has closed an oversubscribed $5.1 million Series A financing round with TechWald Holding joining as a strategic shareholder. TechWald Holding Partner Shlomo Shpun, who brings 25 years of electrophysiology expertise, will join SentiAR's Board of Directors to provide operational guidance. The funding will accelerate commercialization of SentiAR's FDA 510(k) cleared CommandEP system, which demonstrated up to 50% improvement in point navigation accuracy in clinical studies.DAICFDA Clears First Holographic Cardiac Ablation Guidance SystemThe U.S. Food and Drug Administration granted 510(k) clearance for the SentiAR CommandEP system, marking the first approval of a holographic guidance system for invasive cardiac ablation procedures. Clinical studies demonstrated a 44% reduction in mean navigation error compared to standard visualization tools, validating the technology's precision. The system is now available for sale in the United States, with broader distribution expected to begin in 2021.PR NewswireSentiAR Announces FDA 510K Clearance of CommandEP™ System, the First Holographic Cardiac Ablation Guidance SystemSentiAR, a medical technology company, has received U.S. Food and Drug Administration 510(k) clearance for its CommandEP system, the first holographic guidance system for use during invasive cardiac ablation procedures. The system uses Microsoft HoloLens to display real-time 3D holographic images of a patient's heart, enabling electrophysiologists to navigate catheter placement hands-free during procedures. Clinical trials conducted at St. Louis Children's and Barnes Jewish Hospitals demonstrated a 44% reduction in mean navigation error compared to standard visualization tools, and the system is now available for sale in the United States.BioWorldFDA clears first holographic cardiac ablation guidance systemSentiar Inc. received U.S. FDA clearance for its Commandep holographic guidance system for cardiac ablation procedures. The system lets electrophysiologists visualize 3D electroanatomic models in real-time using augmented reality. The system is intended for use as a medical imaging system for review, analysis, communication, and media interchange of multidimensional digital images.PR NewswireSentiAR Names Berk Tas President and CEOSentiAR, a St. Louis-based medical device startup developing augmented reality technology for cardiac ablation procedures, appointed Berk Tas as President and CEO. Tas brings over a decade of experience in the healthcare medical device industry, including leadership roles at Boston Scientific, Sunshine Heart, HLT Medical, and involvement in the acquisition of Sensium. The company is preparing to submit its 3D augmented reality holographic visualization platform to the FDA this year, targeting the treatment of atrial fibrillation which affects 33 million people globally.